DE60006054T2 - Herstellungsverfahren für Pyridinderivate - Google Patents

Herstellungsverfahren für Pyridinderivate Download PDF

Info

Publication number
DE60006054T2
DE60006054T2 DE60006054T DE60006054T DE60006054T2 DE 60006054 T2 DE60006054 T2 DE 60006054T2 DE 60006054 T DE60006054 T DE 60006054T DE 60006054 T DE60006054 T DE 60006054T DE 60006054 T2 DE60006054 T2 DE 60006054T2
Authority
DE
Germany
Prior art keywords
compound
formula
lower alkyl
mmol
reacting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60006054T
Other languages
German (de)
English (en)
Other versions
DE60006054D1 (de
Inventor
Hans Hilpert
Fabienne Hoffmann-Emery
Goesta Rimmler
Mark Rogers-Evans
Helmut Werner Stahr
Pius Waldmeier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of DE60006054D1 publication Critical patent/DE60006054D1/de
Application granted granted Critical
Publication of DE60006054T2 publication Critical patent/DE60006054T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE60006054T 1999-11-29 2000-11-23 Herstellungsverfahren für Pyridinderivate Expired - Lifetime DE60006054T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99123686 1999-11-29
EP99123686 1999-11-29

Publications (2)

Publication Number Publication Date
DE60006054D1 DE60006054D1 (de) 2003-11-27
DE60006054T2 true DE60006054T2 (de) 2004-07-22

Family

ID=8239482

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60006054T Expired - Lifetime DE60006054T2 (de) 1999-11-29 2000-11-23 Herstellungsverfahren für Pyridinderivate

Country Status (12)

Country Link
US (1) US6303790B1 (fr)
EP (1) EP1103546B1 (fr)
JP (1) JP3403164B2 (fr)
KR (1) KR100371121B1 (fr)
CN (1) CN1176908C (fr)
AT (1) ATE252559T1 (fr)
CA (1) CA2326815C (fr)
DE (1) DE60006054T2 (fr)
DK (1) DK1103546T3 (fr)
ES (1) ES2208206T3 (fr)
JO (1) JO2252B1 (fr)
MX (1) MXPA00011670A (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1035115E (pt) * 1999-02-24 2005-01-31 Hoffmann La Roche Derivados de 4-fenilpiridina e a sua utilizacao como antagonistas do receptor nk-1
SI1103545T1 (en) * 1999-11-29 2004-02-29 F. Hoffmann-La Roche Ag 2-(3,5-Bis-trifluoromethyl-phenyl)-N-methyl-N-(6-morpholin-4-yl-4-o-tolyl-pyridin-3-yl)-isobutyramide
TWI287003B (en) * 2000-07-24 2007-09-21 Hoffmann La Roche 4-phenyl-pyridine derivatives
TWI259180B (en) * 2000-08-08 2006-08-01 Hoffmann La Roche 4-Phenyl-pyridine derivatives
US20030083345A1 (en) * 2001-07-10 2003-05-01 Torsten Hoffmann Method of treatment and/or prevention of brain, spinal or nerve injury
ATE375980T1 (de) * 2002-02-12 2007-11-15 Smithkline Beecham Corp Nicotinamide und deren verwendung als p38 inhibitoren
US7288658B2 (en) * 2003-07-15 2007-10-30 Hoffmann-La Roche Inc. Process for preparation of pyridine derivatives
CN1984891B (zh) 2004-07-06 2012-08-08 弗·哈夫曼-拉罗切有限公司 用作合成nk-1受体拮抗剂的中间体的甲酰胺吡啶衍生物的制备方法
KR20070094666A (ko) 2005-02-25 2007-09-20 에프. 호프만-라 로슈 아게 약제 물질 분산성이 향상된 정제
CN103893145A (zh) * 2005-09-23 2014-07-02 弗·哈夫曼-拉罗切有限公司 新型制剂
GB0808747D0 (en) 2008-05-14 2008-06-18 Glaxo Wellcome Mfg Pte Ltd Novel compounds
US8426450B1 (en) 2011-11-29 2013-04-23 Helsinn Healthcare Sa Substituted 4-phenyl pyridines having anti-emetic effect
AU2014286926A1 (en) 2013-07-02 2015-12-17 Eustralis Pharmaceuticals Limited (Trading As Pressura Neuro) Method for preventing and/or treating chronic traumatic encephalopathy-II
CN104003933A (zh) * 2014-05-14 2014-08-27 上海应用技术学院 一种含氟基团的3-（吡啶基-2-亚胺）丙酸乙酯类似物的制备方法
CN105061303A (zh) * 2015-08-03 2015-11-18 成都欣捷高新技术开发有限公司 一种制备奈妥吡坦关键中间体n-甲基-4-(2-甲基苯基)-6-(4-甲基-1-哌嗪基)-3-吡啶胺的新方法
CN105732488B (zh) * 2016-03-28 2018-02-16 大连理工大学 一种吡啶‑2‑甲酸脱羧合成2‑(2‑氯乙氧基)乙氧基吡啶醚化合物的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4745123A (en) 1986-02-18 1988-05-17 Warner-Lambert Company Substituted tetrahydro-3-pyridine-carboxylic acid, ester, and amide cholinergic agents
PT1035115E (pt) 1999-02-24 2005-01-31 Hoffmann La Roche Derivados de 4-fenilpiridina e a sua utilizacao como antagonistas do receptor nk-1

Also Published As

Publication number Publication date
CA2326815C (fr) 2009-08-25
DE60006054D1 (de) 2003-11-27
KR100371121B1 (ko) 2003-02-06
JP3403164B2 (ja) 2003-05-06
ATE252559T1 (de) 2003-11-15
EP1103546B1 (fr) 2003-10-22
ES2208206T3 (es) 2004-06-16
CN1176908C (zh) 2004-11-24
MXPA00011670A (es) 2002-08-20
KR20010051922A (ko) 2001-06-25
US6303790B1 (en) 2001-10-16
EP1103546A1 (fr) 2001-05-30
JO2252B1 (en) 2004-10-07
CA2326815A1 (fr) 2001-05-29
DK1103546T3 (da) 2004-02-23
JP2001151755A (ja) 2001-06-05
CN1297887A (zh) 2001-06-06

Similar Documents

Publication Publication Date Title
DE60006054T2 (de) Herstellungsverfahren für Pyridinderivate
DE69207017T2 (de) Benzamide
DE69524246T2 (de) 1,2,3,4-Tetrahydroquinoxalindion Derivate und ihre Verwendung als Glutamat Rezeptor Antagonisten
DE69533277T2 (de) Dc-89 derivat
EP1778668B1 (fr) Procede de production de dihydropteridinones
DE602004010848T2 (de) Derivate von 1-piperazin- und 1-homopiperazincarboxylaten, verfahren zu deren herstellung und deren verwendung als inhibitoren des faah-enzyms
EP0726899B1 (fr) Nouveaux derives de pyrazinecarboxamide, leur preparation et leur utilisation dans des medicaments
EP0427765B1 (fr) Derives d'alkoxy-4(1h)-pyridone, leurs procedes de preparation et leur emploi comme medicaments
DE68918609T2 (de) Piperidinoalkyl-Derivate von Carbonsäure-Amiden.
DE602004010820T2 (de) Verfahren zur herstellung von 4-aryl-nicotinamidderivaten
DE69533284T2 (de) Neue cyclische und acyclische amide zur erhöhung der neurotransmitter ausschüttung
DE3818830A1 (de) Bicyclische carboxamide, verfahren zu ihrer herstellung, deren vorstufen, und diese verbindungen enthaltende arzneimittel
DE1620035A1 (de) 3-Amino-5-X-6-halogenpyrazinonitrile und Verfahren zu deren Herstellung
DE68906200T2 (de) Kondensierte pyrazol-3-oxo-propannitril-derivate und verfahren zu deren herstellung.
EP0684236A2 (fr) N-(2-Amino-4,6-dichloropyrimidin-5-yl)formamide et procédé pour sa préparation
EP0252005B1 (fr) Composés de 1-benzooxacycloalkyl acides pyridine carboxyliques hydrogénés
EP0119428A2 (fr) Biscarboxamides pour le traitement de maladies et procédé pour leur préparation
DD286581A5 (de) Verfahren zur herstellung von hetera-aliphatischem carbonsaeureamiden
DE2816884A1 (de) Anilinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
DE2461802A1 (de) Pyrazinderivate
EP0519291B1 (fr) 2,3-Dihydropyrano (2,3-b) pyridines amino-méthyl-substituées, procédé pour leur préparation et leur utilisation en tant que médicaments
DE69910083T2 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
DE3433953A1 (de) Neue, eine imidazol-gruppe enthaltende 3,4-dihydro-2(1h)-pyridone und2(1h)-pyridone, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE2841644C2 (fr)
EP0472166A1 (fr) Dérivés tricycliques de pyridone

Legal Events

Date Code Title Description
8364 No opposition during term of opposition